REGENXBIO (RGNX) EBITDA US GAAP (year values) |
||||||||
| 2020 | 2021 | 2022 | 2022 | 2023 | LTM ? | |||
| EBITDA, bln rub | ? | -96.8 | 169.5 | -257.0 | -244.2 | -239.5 | -225.1 | |
| Changes by years, y/y, % | +7% | -275% | -252% | -5% | -2% | |||
REGENXBIO. EBITDA US GAAP, bln rub
REGENXBIO. EBITDA US GAAP, changes, %
REGENXBIO. EBITDA US GAAP, sum by quarters, bln rub
REGENXBIO (RGNX) EBITDA US GAAP (quarter values) |
||||||||
| 2023Q3 | 2023Q4 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA, bln rub | ? | -55.9 | -57.3 | -57.2 | -48.5 | -62.1 | -225.1 | |
| Changes by years, y/y, % | -17% | -1% | -13% | -29% | +11% | |||
| Changes by quarters, q/q, % | -19% | +3% | 0% | -15% | +28% | |||